Bo Feng
Gründer bei Chengwei Evergreen Management LLC
Aktive Positionen von Bo Feng
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Ceyuan Ventures Investment Consulting (BE) Co. Ltd.
 Ceyuan Ventures Investment Consulting (BE) Co. Ltd. Investment ManagersFinance Ceyuan Ventures Investment Consulting (BE) Co. Ltd. is a Chinese venture capital firm which was founded by John S. Wadsworth, Jr., Chris Wadsworth, Feng Tao and Bo Feng in 2004. Based in Beijing with additional offices in Shanghai and San Francisco, Ceyuan Ventures aims to assist entrepreneurs in creating and building world-class businesses through their conviction, network of relationships and grass roots culture. | Direktor/Vorstandsmitglied | 01.03.2004 | - |
| Mitglied des Investmentausschusses | 01.03.2004 | - | |
| Private Equity Investor | 01.03.2004 | - | |
T2CN Holding Ltd.
 T2CN Holding Ltd. Internet Software/ServicesTechnology Services T2CN Holding Ltd. provides online sports and games. The company's products include Freestyle, Pangya Ii, Neo Steam, and Paipaijoy. The firm's partners include Hanbisoft, JCE, Sega, Nike, and Nokia. The company was established on October 10, 2004, and is headquartered in Shanghai, China. | Direktor/Vorstandsmitglied | 01.10.2004 | - |
| Chengwei Evergreen Management LLC | Gründer | 01.01.1999 | - |
| Corporate Officer/Principal | 01.01.1999 | - | |
Eureka Therapeutics, Inc.
 Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Bo Feng
Ehemalige bekannte Positionen von Bo Feng
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| DONGJIANG ENVIRONMENTAL COMPANY LIMITED | Direktor/Vorstandsmitglied | 08.06.2011 | - |
| LIGHTINTHEBOX HOLDING CO., LTD. | Direktor/Vorstandsmitglied | 01.01.2008 | - |
| XUNLEI LIMITED | Direktor/Vorstandsmitglied | 10.06.2011 | - |
Statistik
International
| China | 5 |
| Singapur | 2 |
| Cayman Islands | 2 |
Operativ
| Director/Board Member | 6 |
| Investment Committee Member | 1 |
| Private Equity Investor | 1 |
Sektoral
| Technology Services | 3 |
| Finance | 2 |
| Industrial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| XUNLEI LIMITED | Technology Services |
| DONGJIANG ENVIRONMENTAL COMPANY LIMITED | Industrial Services |
| LIGHTINTHEBOX HOLDING CO., LTD. | Retail Trade |
| Private Unternehmen | 4 |
|---|---|
Ceyuan Ventures Investment Consulting (BE) Co. Ltd.
Ceyuan Ventures Investment Consulting (BE) Co. Ltd. Investment ManagersFinance Ceyuan Ventures Investment Consulting (BE) Co. Ltd. is a Chinese venture capital firm which was founded by John S. Wadsworth, Jr., Chris Wadsworth, Feng Tao and Bo Feng in 2004. Based in Beijing with additional offices in Shanghai and San Francisco, Ceyuan Ventures aims to assist entrepreneurs in creating and building world-class businesses through their conviction, network of relationships and grass roots culture. | Finance |
T2CN Holding Ltd.
T2CN Holding Ltd. Internet Software/ServicesTechnology Services T2CN Holding Ltd. provides online sports and games. The company's products include Freestyle, Pangya Ii, Neo Steam, and Paipaijoy. The firm's partners include Hanbisoft, JCE, Sega, Nike, and Nokia. The company was established on October 10, 2004, and is headquartered in Shanghai, China. | Technology Services |
| Chengwei Evergreen Management LLC | |
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | Health Technology |